Case closed: CRO to pay ‘vindicated’ Cel-Sci $2.9m in damages
Cel-Sci has won the breach of contract ruling against its former CRO inVentiv, after it “slowed down clinical development of Cel-Sci’s Phase III cancer immunotherapy,” says CEO.
Archives for June 27, 2018
WuXi Biologics reveals first HCAb partnership alongside Harbour BioMed
WuXi Biologics has announced it will undertake its first collaborative project to develop and manufacture ‘heavy chain only’ antibodies, through an agreement with Harbour BioMed.
GE Healthcare leaves GE, looks to ‘next chapter’
Separating from parent company GE will offer GE Healthcare greater flexibility to “react quickly to changes in the industry,” says CEO.